Venn Life Sciences

Executive Summary

Venn Life Sciences is an integrated drug development partner based in Ireland, providing end-to-end consultancy and operational services to pharmaceutical and biotechnology companies. Founded in 2008, the company specializes in clinical trial design, execution, and regulatory strategy, supporting clients from discovery through market authorization. By combining strategic planning with hands-on project delivery, Venn aims to accelerate client programs while reducing costs. As a private CRO, it leverages its expertise to navigate complex regulatory landscapes and optimize development timelines. The company's Phase 3 designation reflects its focus on later-stage clinical support, though it offers services across all development phases. With a growing demand for outsourced drug development services, Venn is well-positioned to capture market share, particularly in Europe.

Upcoming Catalysts (preview)

• Q4 2026New Strategic Partnership with a Top-20 Pharma Company65% success
• Q3 2026Expansion of Clinical Trial Services into New Therapeutic Areas70% success
• TBDLaunch of Proprietary Trial Optimization Platform60% success